183 related articles for article (PubMed ID: 34386661)
1. Effect of Vancomycin on the Gut Microbiome and Plasma Concentrations of Gut-Derived Uremic Solutes.
Nazzal L; Soiefer L; Chang M; Tamizuddin F; Schatoff D; Cofer L; Aguero-Rosenfeld ME; Matalon A; Meijers B; Holzman R; Lowenstein J
Kidney Int Rep; 2021 Aug; 6(8):2122-2133. PubMed ID: 34386661
[TBL] [Abstract][Full Text] [Related]
2. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
3. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
[TBL] [Abstract][Full Text] [Related]
5. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
[TBL] [Abstract][Full Text] [Related]
7. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425
[TBL] [Abstract][Full Text] [Related]
8. Reduction in protein-bound solutes unacceptable as marker of dialysis efficacy during alternate-night nocturnal hemodialysis.
Meijers B; Toussaint ND; Meyer T; Bammens B; Verbeke K; Vanrenterghem Y; Kerr PG; Evenepoel P
Am J Nephrol; 2011; 34(3):226-32. PubMed ID: 21791919
[TBL] [Abstract][Full Text] [Related]
9. Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study).
Marzocco S; Fazeli G; Di Micco L; Autore G; Adesso S; Dal Piaz F; Heidland A; Di Iorio B
J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274359
[TBL] [Abstract][Full Text] [Related]
10. Microbe-derived uremic solutes enhance thrombosis potential in the host.
Nemet I; Funabashi M; Li XS; Dwidar M; Sangwan N; Skye SM; Romano KA; Cajka T; Needham BD; Mazmanian SK; Hajjar AM; Rey FE; Fiehn O; Tang WHW; Fischbach MA; Hazen SL
mBio; 2023 Nov; 14(6):e0133123. PubMed ID: 37947418
[No Abstract] [Full Text] [Related]
11. p-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis.
Hyun HS; Paik KH; Cho HY
Korean J Pediatr; 2013 Apr; 56(4):159-64. PubMed ID: 23646054
[TBL] [Abstract][Full Text] [Related]
12. The Impact of CKD on Uremic Toxins and Gut Microbiota.
Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A
Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota as a Source of Uremic Toxins.
Popkov VA; Zharikova AA; Demchenko EA; Andrianova NV; Zorov DB; Plotnikov EY
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008909
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiome and Microbiome-Derived Metabolites in Patients with End-Stage Kidney Disease.
Koshida T; Gohda T; Sugimoto T; Asahara T; Asao R; Ohsawa I; Gotoh H; Murakoshi M; Suzuki Y; Yamashiro Y
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511232
[TBL] [Abstract][Full Text] [Related]
15. Colonic contribution to uremic solutes.
Aronov PA; Luo FJ; Plummer NS; Quan Z; Holmes S; Hostetter TH; Meyer TW
J Am Soc Nephrol; 2011 Sep; 22(9):1769-76. PubMed ID: 21784895
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
17. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
[TBL] [Abstract][Full Text] [Related]
18. Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration.
Böhringer F; Jankowski V; Gajjala PR; Zidek W; Jankowski J
ASAIO J; 2015; 61(1):55-60. PubMed ID: 25419832
[TBL] [Abstract][Full Text] [Related]
19. Functional genomic analysis identifies indoxyl sulfate as a major, poorly dialyzable uremic toxin in end-stage renal disease.
Jhawar S; Singh P; Torres D; Ramirez-Valle F; Kassem H; Banerjee T; Dolgalev I; Heguy A; Zavadil J; Lowenstein J
PLoS One; 2015; 10(3):e0118703. PubMed ID: 25811877
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.
Vanholder R; Pletinck A; Schepers E; Glorieux G
Toxins (Basel); 2018 Jan; 10(1):. PubMed ID: 29316724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
